
GC72873
KKL-40
Also known as N-[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]-3-(trifluoromethyl)benzamide
KKL-40 is an inhibitor that targets the trans-transcription process and is effective against methicillin-sensitive and -resistant Staplococcus aureus as well as other Gram-positive pathogens
ChemicalCAS865285-47-8MW351.26FormulaC16H9F4N3O2
- CAS number
- 865285-47-8
- Molecular weight
- 351.26
- Formula
- C16H9F4N3O2
- Solubility
- DMSO : 25 mg/mL (71·17 mM; Need ultrasonic)
- InChIKey
- AFCDUJHJWVOHTF-UHFFFAOYSA-N
- Catalogue number
- GC72873
- Brand
- GLPBIO
Computed properties PubChem CID 4464310 · XLogP 3.6 · TPSA 68 Ų · H-bond donors 1
- XLogP
- 3.6
- TPSA
- 68 Ų
- H-bond donors
- 1
- H-bond acceptors
- 8
- Rotatable bonds
- 3
- Heavy atoms
- 25
SMILES C1=CC(=CC(=C1)C(F)(F)F)C(=O)NC2=NN=C(O2)C3=CC=C(C=C3)F
Computed descriptors from PubChem (CID 4464310), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il